bf/NASDAQ:TRDA_icon.jpeg

NASDAQ:TRDA

Entrada Therapeutics, Inc.

  • Stock

USD

Last Close

17.10

26/07 20:00

Market Cap

584.36M

Beta: -

Volume Today

78.61K

Avg: 47.59K

PE Ratio

−24.93

PFCF: 4.35

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
net income
-6.99M
-
-8.67M
24.08%
-8.38M
3.38%
-9.90M
18.15%
-14.43M
45.74%
-18.45M
27.84%
-21.67M
17.48%
-23.18M
6.96%
-25.14M
8.45%
-24.63M
2.02%
-6.67M
72.90%
-25.93M
288.49%
35.46M
236.77%
-9.54M
126.91%
23.50M
346.19%
depreciation and amortization
90K
-
98K
8.89%
199K
103.06%
252K
26.63%
302K
19.84%
364K
20.53%
390K
7.14%
466K
19.49%
514K
10.30%
525K
2.14%
541K
3.05%
730K
34.94%
834K
14.25%
736K
11.75%
934K
26.90%
deferred income tax
-3.76M
-
stock based compensation
75K
-
98K
30.67%
164K
67.35%
326K
98.78%
578K
77.30%
1.46M
152.25%
1.79M
23.05%
2.51M
40.02%
2.71M
7.76%
2.88M
6.46%
2.75M
4.41%
3.12M
13.21%
3.40M
8.88%
3.84M
13.10%
3.73M
2.81%
change in working capital
1.18M
-
1.84M
55.93%
-319K
117.34%
1.41M
542.95%
-678K
147.98%
-3.84M
465.93%
-1.65M
57.10%
2.05M
224.54%
-5.54M
370.05%
-5.98M
8.00%
207.01M
3,562.35%
-11.32M
105.47%
-62.33M
450.58%
2.95M
104.74%
-51.65M
1,848.90%
accounts receivables
-6.30M
-
2.55M
140.54%
-1.28M
150.18%
-853K
33.41%
-71.64M
8,298.12%
inventory
6.30M
-
-2.55M
140.54%
1.28M
150.18%
4.02M
214.13%
accounts payables
398K
-
-78K
119.60%
-268K
243.59%
499K
286.19%
80K
83.97%
-1.03M
1,382.50%
2.06M
300.88%
1.54M
25.28%
-2.91M
288.77%
4.59M
258.00%
534K
88.37%
-4.38M
920.22%
-1.36M
68.84%
2.41M
276.26%
-655K
127.22%
other working capital
782K
-
1.92M
145.27%
-51K
102.66%
914K
1,892.16%
-758K
182.93%
-2.81M
270.84%
-3.71M
31.87%
510K
113.76%
-2.63M
615.49%
-10.57M
302.13%
206.48M
2,053.08%
-6.94M
103.36%
-60.97M
778.35%
-2.62M
95.70%
20.65M
886.81%
other non cash items
13K
-
153K
-
-79K
151.63%
142K
279.75%
142K
0%
-30K
121.13%
-103K
243.33%
-237K
130.10%
-1.69M
613.50%
-1.85M
9.52%
1.76M
195.09%
75.86M
4,207.50%
net cash provided by operating activities
-5.64M
-
-6.62M
17.34%
-8.34M
25.85%
-7.91M
5.11%
-14.07M
77.94%
-20.54M
45.94%
-20.99M
2.19%
-18.01M
14.21%
-27.48M
52.60%
-27.30M
0.65%
203.40M
844.94%
-35.09M
117.25%
-24.49M
30.20%
-4.01M
83.62%
-25.52M
535.91%
investments in property plant and equipment
-237K
-
-1.45M
512.24%
-908K
37.42%
-1.54M
70.04%
-806K
47.80%
-1.32M
64.02%
-594K
55.07%
-775K
30.47%
-810K
4.52%
-708K
12.59%
-1.67M
135.59%
-1.52M
8.75%
-1.45M
4.86%
-976K
32.60%
-838K
14.14%
acquisitions net
9.32M
-
38.78M
-
111.73M
188.16%
2.29M
97.95%
purchases of investments
-182.65M
-
-39.32M
-
-101.78M
-
-140.12M
37.68%
-76.79M
45.20%
-88.52M
15.28%
-96.94M
9.51%
sales maturities of investments
1.71M
-
25M
1,358.58%
30M
20%
19.50M
35%
63M
223.08%
28.39M
54.94%
74.50M
162.45%
108.54M
45.69%
123.92M
14.17%
other investing activites
-9.32M
-
-38.78M
-
-111.73M
188.16%
-2.29M
97.95%
26.98M
-
net cash used for investing activites
-237K
-
-1.45M
512.24%
-908K
37.42%
-1.54M
70.04%
-806K
47.80%
-1.32M
64.02%
-181.53M
13,631.69%
24.23M
113.34%
-10.13M
141.83%
18.79M
285.44%
-40.44M
315.22%
-113.26M
180.03%
-3.74M
96.70%
19.04M
609.58%
26.15M
37.31%
debt repayment
common stock issued
60K
-
195K
225%
19.41M
9,852.31%
443K
97.72%
368K
16.93%
690K
87.50%
206K
70.14%
common stock repurchased
284K
-
dividends paid
other financing activites
24.86M
-
149K
99.40%
106K
-
190.75M
179,857.55%
50K
99.97%
11K
78%
-121K
-
129K
206.61%
206K
-
net cash used provided by financing activities
24.86M
-
149K
99.40%
116.39M
78,010.74%
215K
99.82%
106K
50.70%
190.75M
179,857.55%
50K
99.97%
11K
78%
60K
445.45%
358K
496.67%
19.54M
5,356.98%
443K
97.73%
368K
16.93%
690K
87.50%
206K
70.14%
effect of forex changes on cash
net change in cash
18.98M
-
-7.93M
141.76%
107.14M
1,451.77%
-9.24M
108.62%
-14.78M
59.92%
168.89M
1,243.09%
-202.47M
219.88%
6.23M
103.08%
-37.56M
703.12%
-8.15M
78.29%
182.49M
2,338.05%
-147.91M
181.05%
-27.86M
81.16%
15.72M
156.42%
834K
94.69%
cash at beginning of period
27.99M
-
46.97M
67.82%
39.05M
16.87%
146.19M
274.40%
136.95M
6.32%
122.17M
10.79%
291.06M
138.24%
88.59M
69.56%
94.82M
7.03%
57.26M
39.61%
49.11M
14.24%
231.60M
371.62%
83.69M
63.86%
51.88M
38.01%
67.60M
30.30%
cash at end of period
46.97M
-
39.05M
16.87%
146.19M
274.40%
136.95M
6.32%
122.17M
10.79%
291.06M
138.24%
88.59M
69.56%
94.82M
7.03%
57.26M
39.61%
49.11M
14.24%
231.60M
371.62%
83.69M
63.86%
55.83M
33.29%
67.60M
21.08%
68.44M
1.23%
operating cash flow
-5.64M
-
-6.62M
17.34%
-8.34M
25.85%
-7.91M
5.11%
-14.07M
77.94%
-20.54M
45.94%
-20.99M
2.19%
-18.01M
14.21%
-27.48M
52.60%
-27.30M
0.65%
203.40M
844.94%
-35.09M
117.25%
-24.49M
30.20%
-4.01M
83.62%
-25.52M
535.91%
capital expenditure
-237K
-
-1.45M
512.24%
-908K
37.42%
-1.54M
70.04%
-806K
47.80%
-1.32M
64.02%
-594K
55.07%
-775K
30.47%
-810K
4.52%
-708K
12.59%
-1.67M
135.59%
-1.52M
8.75%
-1.45M
4.86%
-976K
32.60%
-838K
14.14%
free cash flow
-5.88M
-
-8.07M
37.28%
-9.24M
14.48%
-9.45M
2.27%
-14.88M
57.40%
-21.86M
46.92%
-21.59M
1.27%
-18.78M
12.98%
-28.29M
50.62%
-28.01M
0.99%
201.73M
820.16%
-36.61M
118.15%
-25.94M
29.15%
-4.99M
80.77%
-26.36M
428.30%

All numbers in USD (except ratios and percentages)